Published in Leukemia on October 01, 1991
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol (2012) 1.53
Interferon-alpha in childhood haematological malignancies. Postgrad Med J (1996) 0.75
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87
Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood (1997) 4.36
Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas. J Histochem Cytochem (1980) 3.47
Updated Kiel classification for lymphomas. Lancet (1988) 3.25
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res (1996) 2.86
Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66
Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res (1996) 2.35
Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol (1985) 2.35
Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation. J Immunol (1998) 2.22
Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch A Pathol Anat Histol (1982) 2.22
Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. Adv Cancer Res (1984) 2.03
Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. Exp Hematol (1993) 2.02
Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer (1975) 1.95
Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology (1991) 1.94
Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood (1998) 1.80
Primary lymphomas of the lung: morphological, immunohistochemical and clinical features. Histopathology (1990) 1.74
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia (2005) 1.72
Splenic marginal zone lymphocytes and related cells in the lymph node: a morphologic and immunohistochemical study. Hum Pathol (1989) 1.69
Kinetics of the graft-versus-leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Blood (1998) 1.59
Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol (1987) 1.59
Mast cells and mast cell neoplasia: a review. Histopathology (1979) 1.52
Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: evidence from phenotyping after rituxan therapy and transfectant cell analyses. Cytometry (2001) 1.52
Rearrangement of the T-cell-receptor beta-chain gene in the diagnosis of lymphoproliferative disorders. Lancet (1985) 1.46
Sinus histiocytosis with massive lymphadenopathy: fifteen new cases. Cancer (1976) 1.46
Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma. Br J Cancer (1999) 1.44
Selective susceptibility of CD34-expressing cells to acquire flow cytometric features of apoptosis/necrosis on exposure to an ammonium chloride-based red blood cell lysing reagent. J Hematother (1998) 1.42
Interference of blood leucocytes in the measurements of immature red cells (reticulocytes) by two different (semi-) automated flow-cytometry technologies. Clin Lab Haematol (1996) 1.42
Mast cell sarcoma of the larynx. J Clin Pathol (1986) 1.41
Subtypes of T-cell chronic lymphatic leukemia. Cancer (1983) 1.39
Bone marrow findings in systemic mastocytosis. Hum Pathol (1985) 1.39
Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes (1999) 1.39
Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells. Cell Immunol (1996) 1.38
Paclitaxel as weekly second-line therapy in patients with advanced pancreatic carcinoma. Anticancer Drugs (2000) 1.37
S-100 protein in Langerhans cells, interdigitating reticulum cells and histiocytosis X cells. Gan (1982) 1.36
Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference. Clin Chem (1999) 1.35
Immunohistology and aetiology of histiocytic necrotizing lymphadenitis. Report of three instructive cases. Histopathology (1983) 1.35
Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood (1998) 1.32
Development of malignant lymphoma in myoepithelial sialadenitis (Sjögren's syndrome). Virchows Arch A Pathol Anat Histol (1982) 1.30
Assessment of bone marrow histology in Hodgkin's disease: correlation with clinical factors. Br J Haematol (1982) 1.30
Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres--a cytohistological study. Histopathology (1979) 1.28
Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol (1998) 1.28
Malignant lymphomas of the nasal cavity and paranasal sinuses. Virchows Arch A Pathol Anat Histopathol (1989) 1.27
Complement receptor subtypes C3b and C3d in lymphatic tissue and follicular lymphoma. Br J Cancer (1978) 1.27
Malignant lymphomas of B-cell type. Lancet (1972) 1.27
Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood (1999) 1.25
[Interdigitating reticulum cell in the human lymph node. A specific cell of the thymus dependent region (author's transl)]. Virchows Arch B Cell Pathol (1974) 1.25
Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group. Ann Oncol (1995) 1.24
Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol (1999) 1.22
Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood (1994) 1.20
Propagation of large numbers of T cells with natural killer cell markers. Br J Haematol (1994) 1.19
[Tissue mast cell count in immunocytoma and chronic lymphocytic leukaemia (author's transl)]. Virchows Arch A Pathol Anat Histol (1977) 1.19
Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol (1986) 1.17
Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders. J Clin Invest (1986) 1.17
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma. J Clin Oncol (1998) 1.15
Cytological and functional criteria for the classification of malignant lymphomata. Br J Cancer Suppl (1975) 1.13
[Hodgkin's disease with constantly high content of epithelioid cells]. Virchows Arch A Pathol Pathol Anat (1968) 1.12
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C. Leukemia (2003) 1.11
Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12. Cancer Immunol Immunother (1998) 1.11
The complexity of immunohistochemical staining pattern of Hodgkin and Sternberg-reed cells--demonstration of immunoglobulin, albumin, alpha1-antichymotrypsin and lysozyme. Int J Cancer (1978) 1.11
Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol (1989) 1.10
Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings. Virchows Arch B Cell Pathol Incl Mol Pathol (1979) 1.09
Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European Burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis. Int J Cancer (1976) 1.09
Malignant thymoma: current status of classification and multimodality treatment. Ann Hematol (2003) 1.09
Lymphoblastic lymphoma of convoluted or acid phosphatase type-a tumor of T precursor cells. Int J Cancer (1976) 1.08
Recombinant human erythropoietin in patients with myelodysplastic syndrome and myelofibrosis. Acta Haematol (1993) 1.08
Combined immunohistochemical staining for surface IgD and T-lymphocyte subsets with monoclonal antibodies in human tonsils. Histochem J (1983) 1.07
Malignant lymphoma of plasmacytoid T-cells. Morphologic and immunologic studies characterizing a special type of T-cell. Am J Surg Pathol (1983) 1.07
Childhood obsessive-compulsive disorder: a prospective follow-up study. J Child Psychol Psychiatry (1990) 1.06
The relevance of alpha-naphthyl acetate esterases to various monocyte functions. Br J Haematol (1985) 1.06
Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular). J Cancer Res Clin Oncol (1984) 1.06
Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet (1989) 1.05
Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type in Waldeyer's ring. Histopathology (1994) 1.05
Immature sinus histiocytes. Their identification as a novel B-cell population. Am J Pathol (1984) 1.05
Tissue mast cells in health and disease. Pathol Res Pract (1985) 1.04
Clonal rearrangements of T-cell receptor and immunoglobulin genes and immunophenotypic antigen expression in different subclasses of Hodgkin's disease. Int J Cancer (1987) 1.04
Letter: T-associated plasma-cells. Lancet (1975) 1.03
Splenic marginal zone lymphomas of mice. Am J Pathol (1999) 1.03
Vascular transformation of lymph node sinuses due to venous obstruction. Arch Pathol (1971) 1.02
Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Ann Intern Med (1992) 1.02
[Lymphocytes and their functional forms - morphology, organization and immunologic significance]. Verh Anat Ges (1975) 1.01
Abnormal expression of the B-cell homing chemokine receptor BLR1 during the progression of acquired immunodeficiency syndrome. Blood (1997) 1.01
Acute anterior myocardial infarction as first manifestation of acute myeloid leukemia. Ann Hematol (2001) 1.01
Immunocytology of plasmacytoid T cells: marker analysis indicates a unique phenotype of this enigmatic cell. Hum Pathol (1987) 1.00
Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes). Br J Cancer (1980) 0.99
Modulation of cell surface markers on NK-like T lymphocytes by using IL-2, IL-7 or IL-12 in vitro stimulation. Cytokine (2000) 0.99
Rearrangement of T-cell delta locus in lymphoproliferative disorders. Blood (1988) 0.98
Analysis of the p53 and MDM-2 gene in acute myeloid leukemia. Eur J Haematol (1996) 0.98
Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy. Cancer (1997) 0.98
Histological and immunohistological findings in lymphoepithelioid cell lymphoma (Lennert's lymphoma). Am J Surg Pathol (1988) 0.97
Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am J Pathol (1988) 0.97
High-grade non-Hodgkin's lymphoma of B-cell type. I. Histopathology. Histopathology (1988) 0.97
Quantitative fluorescence flow cytometry: a comparison of the three techniques for direct and indirect immunofluorescence. Cytometry (1998) 0.96